IBB vs IEFA
iShares Biotechnology ETF vs iShares Core MSCI EAFE ETF
- • IEFA has the lower expense ratio at 0.07% vs 0.44% for IBB.
- • IEFA pays a higher dividend yield (3.32%).
Side-by-side metrics
| Metric | IBB | IEFA |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.44% | 0.07% |
Dividend yield Trailing 12-month yield. | 0.23% | 3.32% |
AUM Assets under management — bigger funds are typically more liquid. | $7.95B | $180.74B |
YTD return | 3.10% | 9.46% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.74 | 0.91 |
P/E ratio | 23.72 | 18.11 |
Last price | $170.10 | $96.28 |
Inception | — | — |
Issuer | iShares | iShares |
IBB top holdings
| AMGN | Amgen Inc | 7.37% |
| GILD | Gilead Sciences Inc | 7.32% |
| VRTX | Vertex Pharmaceuticals Inc | 7.21% |
| REGN | Regeneron Pharmaceuticals Inc | 6.55% |
| ALNY | Alnylam Pharmaceuticals Inc | 3.71% |
| ARGX | argenx SE ADR | 3.33% |
| INSM | Insmed Inc | 2.70% |
| BIIB | Biogen Inc | 2.67% |
| NTRA | Natera Inc | 2.40% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 2.27% |
IEFA top holdings
| ASML.AS | ASML Holding NV | 2.17% |
| HSBA.L | HSBC Holdings PLC | 1.24% |
| AZN.L | AstraZeneca PLC | 1.15% |
| ROP.SW | Roche Holding AG Ordinary Shares new | 1.13% |
| NOVN.SW | Novartis AG Registered Shares | 1.09% |
| NESN.SW | Nestle SA | 1.04% |
| SHEL.L | Shell PLC | 1.01% |
| SIE.DE | Siemens AG | 0.88% |
| CBA.AX | Commonwealth Bank of Australia | 0.83% |
| 8306.T | Mitsubishi UFJ Financial Group Inc | 0.81% |
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $7.9B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.23%. Its largest holding is Amgen Inc (AMGN), which represents 7.4% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.
About IEFA
IEFA (iShares Core MSCI EAFE ETF) is Developed-market equities ex-US/Canada. Managed by iShares, the fund carries $180.7B in assets under management, an expense ratio of 0.07%, a dividend yield of 3.32%. Its largest holding is ASML Holding NV (ASML.AS), which represents 2.2% of the portfolio. Real Estate is the fund's largest sector exposure at 3.1%.